Antagonists of organic anion transporters 1 and 3 ameliorate adverse cardiac remodelling induced by uremic toxin indoxyl sulfate.

[1]  A. Coats,et al.  Statement on authorship and publishing ethics in the International Journal of Cardiology. , 2011, International journal of cardiology.

[2]  R. Virmani,et al.  Evaluation with in vivo optical coherence tomography and histology of the vascular effects of the everolimus-eluting bioresorbable vascular scaffold at two years following implantation in a healthy porcine coronary artery model: implications of pilot results for future pre-clinical studies , 2011, The International Journal of Cardiovascular Imaging.

[3]  H. Fujii,et al.  Role of Oxidative Stress and Indoxyl Sulfate in Progression of Cardiovascular Disease in Chronic Kidney Disease , 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[4]  T. Niwa.  Role of Indoxyl Sulfate in the Progression of Chronic Kidney Disease and Cardiovascular Disease: Experimental and Clinical Effects of Oral Sorbent AST‐120 , 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.

[5]  H. Krum,et al.  Does indoxyl sulfate, a uraemic toxin, have direct effects on cardiac fibroblasts and myocytes? , 2010, European heart journal.

[6]  Theodore A Bass,et al.  Impact of stent deployment procedural factors on long-term effectiveness and safety of sirolimus-eluting stents (final results of the multicenter prospective STLLR trial). , 2008, The American journal of cardiology.

[7]  P. Fitzgerald,et al.  Vascular response to sirolimus‐eluting stents delivered with a nonaggressive implantation technique: Comparison of intravascular ultrasound results from the multicenter, randomized E‐SIRIUS, and SIRIUS trials , 2005, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.

[8]  A. Enomoto,et al.  Role of organic anion transporters in the tubular transport of indoxyl sulfate and the induction of its nephrotoxicity. , 2002, Journal of the American Society of Nephrology : JASN.

[9]  K. Maeda,et al.  Accumulation of indoxyl sulfate, an inhibitor of drug-binding, in uremic serum as demonstrated by internal-surface reversed-phase liquid chromatography. , 1988, Clinical chemistry.

[10]  P. Gulyassy,et al.  Determination of indoxyl sulfate in plasma of patients with renal failure by use of ion-pairing liquid chromatography. , 1986, Clinical chemistry.